Document Type

Editorial

Publication Date

5-1-2007

Comments

This article has been peer reviewed. It is the authors' final version prior to publication in Skinmed

Volume 6, Issue 3, May-June 2007, Pages 105-6.

The published version is available at PMID: 17478985. Copyright © Pulse Marketing & Communications, LLC

Abstract

It seems that the practicing dermatologist in 2007 is being attacked on all fronts. The Food and Drug Administration has mandated a cumbersome program for monitoring isotrentinoin usage, its analogue barely comes under scrutiny. iPledge is just a plain nightmare. The acumen of the board certified dermatologist is being challenged by Maintenance of Certification proposals because other specialties are doing it; yet, the neighborhood pharmacist is unhampered in dispensing all sorts of advice about treatment. The insurance clerk thrives on denying medication, prescribed by the physician, using flawed reasoning or else suggesting that a ten days’ supply of medicine should be increased to 90 days in the name of economy, thus even further demeaning the sacrosanct prescription concept.

PubMed ID

17478985

Download

Included in

Dermatology Commons

Share

COinS